GlobalData on MSN3d
Boehringer Ingelheim and Salipro enter drug discovery partnership
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Fierce Biotech4d
Sotio takes up option on ADCs, while Boehringer inks GPCR discovery pact
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
Basingstoke Gazette on MSN1d
New initiative aims to improve chronic kidney disease screening
The new initiative aims to improve early detection by increasing access to screening in communities where accessing care is ...
Fierce Biotech5d
Boehringer Ingelheim teams with Veeva to launch new R&D platform One Medicine
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
Contract Pharma6d
Cognizant and Boehringer Ingelheim Launch One Medicine Platform
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
The Pharma Letter5d
Boehringer launches unified platform with Veeva
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, ...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
The Pharma Letter4d
Salipro Biotech inks deal with Boehringer
Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...
Boehringer Ingelheim and Cognizant announce the launch of a unified cloud platform to bring innovative therapies to patients faster
Cognizant (Nasdaq: CTSH) and Boehringer Ingelheim announced today the go-live of an end-to-end technology platform powered by ...